Anti‐leukaemic activity of a novel haploidentical‐transplantation approach employing unmanipulated bone marrow followed by CD6‐depleted peripheral blood stem cells in children with refractory/relapsed acute leukaemia
Open Access
- 6 July 2013
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 162 (6) , 802-807
Abstract
The treatment outcome of children with refractory acute leukaemia or relapse post‐stem cell transplantation is dismal. We report 10 children (non‐remission n = 7) who underwent a new haploidentical transplant approach utilizing unmanipulated bone marrow followed by CD6‐depleted peripheral blood stem cells. Nine patients had successful engraftment and no evidence of leukaemia. Acute and chronic graft‐versus‐host‐disease was observed in five and three patients, respectively; two patients died of treatment‐related toxicity. Seven patients relapsed after 7 (range 3–34) months, however two patients are alive at 6·5 and 7·0 years. This approach provides anti‐leukaemic activity even in heavily pre‐treated children but long‐term disease control requires further intervention.Keywords
This publication has 14 references indexed in Scilit:
- Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant groupBlood, 2010
- Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAbJournal of Allergy and Clinical Immunology, 2008
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideTransplantation and Cellular Therapy, 2008
- Partially Matched, Nonmyeloablative Allogeneic Transplantation: Clinical Outcomes and Immune ReconstitutionJournal of Clinical Oncology, 2007
- CD8+ T‐cell memory in tumor immunology and immunotherapyImmunological Reviews, 2006
- Haploidentical transplantation for acute lymphoblastic leukemia in childhoodBlood Reviews, 2004
- Long‐term follow‐up of relapsed childhood acute lymphoblastic leukaemiaBritish Journal of Haematology, 2003
- Tolerance and chimerism1Transplantation, 2003
- Risk factors for cytomegalovirus reactivation after CD6+ T-cell???depleted allogeneic bone marrow transplantation1Transplantation, 2002
- Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patientsBlood, 1990